Does vitamin C matter? A quest for in vivo effects of vitamin C deficiency

Research output: Contribution to journalConference abstract in journalResearch

Standard

Does vitamin C matter? A quest for in vivo effects of vitamin C deficiency. / Lykkesfeldt, Jens.

In: Free Radical Research, Vol. 42, No. S1, 2008, p. s23.

Research output: Contribution to journalConference abstract in journalResearch

Harvard

Lykkesfeldt, J 2008, 'Does vitamin C matter? A quest for in vivo effects of vitamin C deficiency', Free Radical Research, vol. 42, no. S1, pp. s23.

APA

Lykkesfeldt, J. (2008). Does vitamin C matter? A quest for in vivo effects of vitamin C deficiency. Free Radical Research, 42(S1), s23.

Vancouver

Lykkesfeldt J. Does vitamin C matter? A quest for in vivo effects of vitamin C deficiency. Free Radical Research. 2008;42(S1):s23.

Author

Lykkesfeldt, Jens. / Does vitamin C matter? A quest for in vivo effects of vitamin C deficiency. In: Free Radical Research. 2008 ; Vol. 42, No. S1. pp. s23.

Bibtex

@article{37e02000a1c411ddb6ae000ea68e967b,
title = "Does vitamin C matter? A quest for in vivo effects of vitamin C deficiency",
abstract = "Vitamin C has long been recognized as an important dietary micronutrient based on its ability to prevent scurvy in humans. Moreover, over the past decades, ascorbate has been identified as a powerful redox modulator and named {\textquoteleft}{\textquoteleft}the most important antioxidant in plasma''. Several investigators have shown ascorbate to be an excellent biomarker of {\textquoteleft}{\textquoteleft}oxidative stress'' in a variety of biological settings from isolated cells to humans. However, in spite of the amazing redox powers of ascorbate, little evidence has been presented until now demonstrating that vitamin C deficiency results in any clinical manifestation beyond that of scurvy. Meanwhile, literally hundreds of millions of people worldwide can be diagnosed with hypovitaminosis C, i.e. a plasma concentration below 23 mmol/L, a condition that is typically chronic due to e.g. sustained malnutrition, smoking or disease. The magnitude of this potential problem has prompted discussions on the possible beneficial effect of supplementation to humans as a preventive measure but so far large clinical trials have shown no clinical relevance of antioxidant supplementation in general. Two possible pathological consequences of marginal vitamin C deficiency are discussed and supported by new in vivo evidence from animal studies. Apparently, vitamin C does matter. . .",
author = "Jens Lykkesfeldt",
note = "Udgivelsesdato: July 2008 Volumne: 42; null ; Conference date: 05-07-2008",
year = "2008",
language = "English",
volume = "42",
pages = "s23",
journal = "Free Radical Research",
issn = "1071-5762",
publisher = "Taylor & Francis",
number = "S1",

}

RIS

TY - ABST

T1 - Does vitamin C matter? A quest for in vivo effects of vitamin C deficiency

AU - Lykkesfeldt, Jens

N1 - Udgivelsesdato: July 2008 Volumne: 42

PY - 2008

Y1 - 2008

N2 - Vitamin C has long been recognized as an important dietary micronutrient based on its ability to prevent scurvy in humans. Moreover, over the past decades, ascorbate has been identified as a powerful redox modulator and named ‘‘the most important antioxidant in plasma''. Several investigators have shown ascorbate to be an excellent biomarker of ‘‘oxidative stress'' in a variety of biological settings from isolated cells to humans. However, in spite of the amazing redox powers of ascorbate, little evidence has been presented until now demonstrating that vitamin C deficiency results in any clinical manifestation beyond that of scurvy. Meanwhile, literally hundreds of millions of people worldwide can be diagnosed with hypovitaminosis C, i.e. a plasma concentration below 23 mmol/L, a condition that is typically chronic due to e.g. sustained malnutrition, smoking or disease. The magnitude of this potential problem has prompted discussions on the possible beneficial effect of supplementation to humans as a preventive measure but so far large clinical trials have shown no clinical relevance of antioxidant supplementation in general. Two possible pathological consequences of marginal vitamin C deficiency are discussed and supported by new in vivo evidence from animal studies. Apparently, vitamin C does matter. . .

AB - Vitamin C has long been recognized as an important dietary micronutrient based on its ability to prevent scurvy in humans. Moreover, over the past decades, ascorbate has been identified as a powerful redox modulator and named ‘‘the most important antioxidant in plasma''. Several investigators have shown ascorbate to be an excellent biomarker of ‘‘oxidative stress'' in a variety of biological settings from isolated cells to humans. However, in spite of the amazing redox powers of ascorbate, little evidence has been presented until now demonstrating that vitamin C deficiency results in any clinical manifestation beyond that of scurvy. Meanwhile, literally hundreds of millions of people worldwide can be diagnosed with hypovitaminosis C, i.e. a plasma concentration below 23 mmol/L, a condition that is typically chronic due to e.g. sustained malnutrition, smoking or disease. The magnitude of this potential problem has prompted discussions on the possible beneficial effect of supplementation to humans as a preventive measure but so far large clinical trials have shown no clinical relevance of antioxidant supplementation in general. Two possible pathological consequences of marginal vitamin C deficiency are discussed and supported by new in vivo evidence from animal studies. Apparently, vitamin C does matter. . .

M3 - Conference abstract in journal

VL - 42

SP - s23

JO - Free Radical Research

JF - Free Radical Research

SN - 1071-5762

IS - S1

Y2 - 5 July 2008

ER -

ID: 8112140